183 related articles for article (PubMed ID: 31203222)
1. Correlates of Successful Rheumatoid Arthritis Flare Management: Clinician-driven Treatment, Home-based Strategies, and Medication Change.
Mahmoud TG; Huang J; Frits M; Iannaccone C; Bykerk V; Bingham CO; Weinblatt M; Shadick NA
J Rheumatol; 2020 Mar; 47(3):333-340. PubMed ID: 31203222
[TBL] [Abstract][Full Text] [Related]
2. Flares in rheumatoid arthritis: frequency and management. A report from the BRASS registry.
Bykerk VP; Shadick N; Frits M; Bingham CO; Jeffery I; Iannaccone C; Weinblatt M; Solomon DH
J Rheumatol; 2014 Feb; 41(2):227-34. PubMed ID: 24334643
[TBL] [Abstract][Full Text] [Related]
3. Flares in Patients with Rheumatoid Arthritis after Total Hip and Total Knee Arthroplasty: Rates, Characteristics, and Risk Factors.
Goodman SM; Bykerk VP; DiCarlo E; Cummings RW; Donlin LT; Orange DE; Hoang A; Mirza S; McNamara M; Andersen K; Bartlett SJ; Szymonifka J; Figgie MP
J Rheumatol; 2018 May; 45(5):604-611. PubMed ID: 29545451
[TBL] [Abstract][Full Text] [Related]
4. Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes.
Bechman K; Tweehuysen L; Garrood T; Scott DL; Cope AP; Galloway JB; Ma MHY
J Rheumatol; 2018 Nov; 45(11):1515-1521. PubMed ID: 30173149
[TBL] [Abstract][Full Text] [Related]
5. Pain and Self-reported Swollen Joints Are Main Drivers of Patient-reported Flares in Rheumatoid Arthritis: Results from a 12-month Observational Study.
Kuettel D; Primdahl J; Weber U; Terslev L; Østergaard M; Petersen R; Pedersen AK; Möller S; Hørslev-Petersen K
J Rheumatol; 2020 Sep; 47(9):1305-1313. PubMed ID: 31787604
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer.
McCarter KR; Arabelovic S; Wang X; Wolfgang T; Yoshida K; Qian G; Kowalski EN; Vanni KMM; LeBoeuf NR; Buchbinder EI; Gedmintas L; MacFarlane LA; Rao DA; Shadick NA; Gravallese EM; Sparks JA
Semin Arthritis Rheum; 2024 Feb; 64():152335. PubMed ID: 38100899
[TBL] [Abstract][Full Text] [Related]
7. Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire.
Myasoedova E; De Thurah A; Erpelding ML; Schneeberger EE; Maribo T; Citera G; Davis JM; Matteson EL; Crowson CS; Fautrel B; Guillemin F
Semin Arthritis Rheum; 2020 Apr; 50(2):261-265. PubMed ID: 31526593
[TBL] [Abstract][Full Text] [Related]
8. Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study.
Markusse IM; Dirven L; Gerards AH; van Groenendael JH; Ronday HK; Kerstens PJ; Lems WF; Huizinga TW; Allaart CF
Arthritis Res Ther; 2015 Aug; 17(1):232. PubMed ID: 26321751
[TBL] [Abstract][Full Text] [Related]
9. Validation of OMERACT preliminary rheumatoid arthritis flare domains in the NOR-DMARD study.
Lie E; Woodworth TG; Christensen R; Kvien TK; Bykerk V; Furst DE; Bingham CO; Choy EH;
Ann Rheum Dis; 2014 Oct; 73(10):1781-7. PubMed ID: 23852690
[TBL] [Abstract][Full Text] [Related]
10. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
[TBL] [Abstract][Full Text] [Related]
11. The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA).
Barroso N; Woodworth TG; Furst DE; Guillemin F; Fautrel BJ; Borazan N; Kafaja S; Brook J; Elashoff DA; Ranganath VK
Clin Rheumatol; 2020 Jan; 39(1):189-199. PubMed ID: 31493148
[TBL] [Abstract][Full Text] [Related]
12. Prediction of disease flare by biomarkers after discontinuing biologics in patients with rheumatoid arthritis achieving stringent remission.
Kameda H; Hirata A; Katagiri T; Takakura Y; Inoue Y; Takenaka S; Ito H; Mizushina K; Ogura T
Sci Rep; 2021 Mar; 11(1):6865. PubMed ID: 33767314
[TBL] [Abstract][Full Text] [Related]
13. Improved flare and remission pattern in rheumatoid arthritis over recent decades: a population-based study.
Raheel S; Matteson EL; Crowson CS; Myasoedova E
Rheumatology (Oxford); 2017 Dec; 56(12):2154-2161. PubMed ID: 28968703
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients.
van den Brandt S; Zbinden A; Baeten D; Villiger PM; Østensen M; Förger F
Arthritis Res Ther; 2017 Mar; 19(1):64. PubMed ID: 28320445
[TBL] [Abstract][Full Text] [Related]
15. Understanding Differences in Patient Descriptions of Rheumatoid Arthritis Flares Using OMERACT Core Domains.
Maica GL; Iannaccone C; Feathers V; Frits ML; Bykerk VP; Bingham CO; Weinblatt M; Shadick NA
J Rheumatol; 2023 Jul; 50(7):889-894. PubMed ID: 36725063
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes after discontinuing biological drugs and tofacitinib in patients with rheumatoid arthritis: A prospective cohort study.
Mori S; Okada A; Koga T; Ueki Y
PLoS One; 2022; 17(6):e0270391. PubMed ID: 35737642
[TBL] [Abstract][Full Text] [Related]
17. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
Ciubotariu E; Gabay C; Finckh A;
J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
[TBL] [Abstract][Full Text] [Related]
18. Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity.
Holten K; Paulshus Sundlisæter N; Sexton J; Nordberg LB; Uhlig T; Kvien TK; Solomon DH; Haavardsholm EA; Lillegraven S; Aga AB;
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38216290
[TBL] [Abstract][Full Text] [Related]
19. Validation and predictive capacity of a Dutch version of the FLARE-RA questionnaire within the context of a TNFi-tapering trial.
Doumen M; Bertrand D; Pazmino S; De Cock D; Stouten V; Joly J; de Wergifosse I; Moeyersoons A; Westhovens R; Verschueren P
Clin Rheumatol; 2023 Jan; 42(1):39-45. PubMed ID: 35943667
[TBL] [Abstract][Full Text] [Related]
20. Do Poor Prognostic Factors in Rheumatoid Arthritis Affect Treatment Choices and Outcomes? Analysis of a US Rheumatoid Arthritis Registry.
Alemao E; Litman HJ; Connolly SE; Kelly S; Hua W; Rosenblatt L; Rebello S; Kremer JM; Harrold LR
J Rheumatol; 2018 Oct; 45(10):1353-1360. PubMed ID: 29961696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
